Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.15 +0.11 (+2.72%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Convertible Debt (2017 - 2018)

Updated

Adial Pharmaceuticals' Convertible Debt came in at $132,854 for Q2 2018.

Analysis

Adial Pharmaceuticals (ADIL) Convertible Debt (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Adial Pharmaceuticals 18.67 Mn 18.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 132,854.00
Dec 31, 2017 132,854.00
API Access

Adial Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ADIL&period=max&api_key=YOUR_API_KEY